Pharmacology : nature.com subject feeds4d agoAntagonizing NRG1-ERBB4 signaling pathway with spironolactone for the treatment of schizophrenia: results of a randomized controlled drug repositioning clinical trialAlkomiet Hasan et al.Read at Pharmacology : nature.com subject feedsTagsmedicinepharmacologypsychiatry
